The Influence of Gender on Aspirin's Effectiveness in Preventing Heart Attacks
Author Information
Author(s): Yerman Todd, Gan Wen Q, Sin Don D
Primary Institution: University of British Columbia
Hypothesis
Does the gender mix in clinical trials affect the efficacy of aspirin in preventing myocardial infarction?
Conclusion
Gender accounts for a substantial proportion of the variability in the efficacy of aspirin in reducing myocardial infarction rates across these trials.
Supporting Evidence
- Aspirin reduced the risk of non-fatal myocardial infarction compared to placebo.
- 27% of the variation in non-fatal MI results could be accounted for by the gender mix of the trials.
- Trials with predominantly male participants showed a larger risk reduction in non-fatal MI.
Takeaway
This study found that aspirin works better for men than for women when it comes to preventing heart attacks.
Methodology
A systematic review and meta-analysis of randomized placebo-controlled trials examining aspirin's efficacy on myocardial infarction.
Potential Biases
There is a possibility of publication or selection bias due to the nature of systematic reviews.
Limitations
The study lacked access to primary data and could not determine the influence of other risk factors associated with aspirin resistance.
Participant Demographics
49.3% of participants were men, with a mean age ranging from 52 to 73 years.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI 0.64–0.81
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website